|
Name |
Pestalotiopyrone G
|
| Molecular Formula | C10H12O3 | |
| IUPAC Name* |
6-[(Z)-but-2-en-2-yl]-4-methoxypyran-2-one
|
|
| SMILES |
C/C=C(/C)\C1=CC(=CC(=O)O1)OC
|
|
| InChI |
InChI=1S/C10H12O3/c1-4-7(2)9-5-8(12-3)6-10(11)13-9/h4-6H,1-3H3/b7-4-
|
|
| InChIKey |
HOXZLCMLRLXRIN-DAXSKMNVSA-N
|
|
| Synonyms |
Pestalotiopyrone G
|
|
| CAS | NA | |
| PubChem CID | 52920646 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 180.2 | ALogp: | 2.1 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 35.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 13 | QED Weighted: | 0.702 |
| Caco-2 Permeability: | -4.585 | MDCK Permeability: | 0.00001870 |
| Pgp-inhibitor: | 0.109 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.016 |
| 30% Bioavailability (F30%): | 0.996 |
| Blood-Brain-Barrier Penetration (BBB): | 0.106 | Plasma Protein Binding (PPB): | 91.80% |
| Volume Distribution (VD): | 0.946 | Fu: | 21.41% |
| CYP1A2-inhibitor: | 0.969 | CYP1A2-substrate: | 0.947 |
| CYP2C19-inhibitor: | 0.633 | CYP2C19-substrate: | 0.61 |
| CYP2C9-inhibitor: | 0.158 | CYP2C9-substrate: | 0.225 |
| CYP2D6-inhibitor: | 0.225 | CYP2D6-substrate: | 0.641 |
| CYP3A4-inhibitor: | 0.067 | CYP3A4-substrate: | 0.417 |
| Clearance (CL): | 11.227 | Half-life (T1/2): | 0.725 |
| hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.896 |
| Drug-inuced Liver Injury (DILI): | 0.54 | AMES Toxicity: | 0.042 |
| Rat Oral Acute Toxicity: | 0.049 | Maximum Recommended Daily Dose: | 0.06 |
| Skin Sensitization: | 0.127 | Carcinogencity: | 0.734 |
| Eye Corrosion: | 0.871 | Eye Irritation: | 0.978 |
| Respiratory Toxicity: | 0.204 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002315 | ![]() |
1.000 | D05CKR | ![]() |
0.258 | ||
| ENC002656 | ![]() |
0.698 | D0DJ1B | ![]() |
0.242 | ||
| ENC002754 | ![]() |
0.620 | D0FA2O | ![]() |
0.242 | ||
| ENC003501 | ![]() |
0.563 | D0AN7B | ![]() |
0.239 | ||
| ENC001650 | ![]() |
0.532 | D09GYT | ![]() |
0.230 | ||
| ENC003971 | ![]() |
0.500 | D08SKH | ![]() |
0.227 | ||
| ENC002737 | ![]() |
0.469 | D0E9CD | ![]() |
0.226 | ||
| ENC002736 | ![]() |
0.451 | D0G4KG | ![]() |
0.222 | ||
| ENC005908 | ![]() |
0.442 | D02XJY | ![]() |
0.217 | ||
| ENC002479 | ![]() |
0.431 | D02DPU | ![]() |
0.212 | ||